Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q2 Results Top Estimates - Update

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.

RTTNews | Pred 91 dňami

Regeneron Pharma Expects Q4 Results To Include $24 Mln In Acquired In-process R&D Charge

Regeneron Pharmaceuticals, Inc. (REGN) said Monday it currently expects that its financial results for the second quarter 2024 will include an acquired in-process research and development charge of approximately $24 million on a pre-tax basis.

RTTNews | Pred 115 dňami

Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

RTTNews | Pred 125 dňami

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.

RTTNews | Pred 853 dňami

Dollar Turns In Mixed Performance Ahead Of Jobs Data

The U.S. dollar recovered from early losses on Thursday after fairly encouraging economic data dashed hopes of any aggressive interest rate cut by the Federal Reserve next week, but gave up gains as the day progressed with investors awaiting non-farm payroll data due on Friday, and the presidential election next week.

RTTNews | Pred 4 h 50 min

Canadian Market Headed For Weak Close

Disappointing earnings updates from U.S. tech majors Microsoft Inc., and Meta Platforms, anxiety ahead of U.S. presidential election and the Federal Reserve's monetary policy meeting, and weak commodity prices are weighing on the Canadian market.

RTTNews | Pred 6 h 50 min

Swiss Market Ends Weak Again

For the second consecutive day, the Switzerland market languished in red right through the day's session, as weak earnings updates from U.S. technology majors Microsoft Inc., and Meta Platforms, and weak euro zone inflation data hurt sentiment and sent stock prices drifting down south on Thursday.

RTTNews | Pred 7 h 40 min

Pound Falls After Autumn Statement

The pound weakened against its major counterparts in the New York session on Thursday, following the announcement of the nation's latest budget, which included tax rises and big spending plans.

RTTNews | Pred 7 h 41 min

EURUSD	1.08834	GBPUSD	1.28982	AUDUSD	0.6578
USDJPY	151.989	USDCAD	1.393	USDCHF	0.86354